Today: 22 May 2026
Lockheed Martin stock pops in US premarket as Trump touts $1.5 trillion military budget, buyback ban looms
8 January 2026
1 min read

Lockheed Martin stock pops in US premarket as Trump touts $1.5 trillion military budget, buyback ban looms

New York, January 8, 2026, 06:00 EST — Premarket

  • Lockheed Martin shares rose about 7% in premarket trading, bucking softer index futures.
  • Traders weighed a bigger U.S. military budget pitch against a White House push to curb buybacks and dividends at defense contractors.
  • Focus turns to Friday’s U.S. jobs report and Lockheed’s January 29 earnings for clarity on cash returns and production plans.

Lockheed Martin shares jumped about 7% in premarket trading on Thursday after President Donald Trump called for a $1.5 trillion U.S. military budget for 2027, lifting defense contractors even as broader stock index futures edged lower ahead of key U.S. labor data. “A move toward more government intervention would create uncertainty,” said Mohit Kumar, an economist at Jefferies. Reuters

The bounce matters because Washington’s message to the sector has turned erratic in 24 hours: spend more, but hand less back to shareholders unless factories move faster. A White House fact sheet said Trump signed an executive order aimed at stopping defense contractors from prioritizing stock buybacks and “excessive corporate distributions” over production capacity and on-time delivery, and it directed officials to press for contract terms that can restrict payouts during periods of underperformance. The White House

The stock had been hit in regular trading on Wednesday as investors digested the threat of limits on dividends and share repurchases. Lockheed fell 4.82% to close at $496.87, according to MarketWatch data.

Other prime contractors also advanced in early trading. Northrop Grumman rose more than 6% and RTX gained about 5%, even after Trump’s order sparked a rotation debate inside the sector, with Saxo Bank strategist Neil Wilson saying, “Geopolitics is the inescapable story of 2026 thus far.” Reuters

Lockheed has its own production narrative running alongside the politics. The company said on Tuesday it signed a framework agreement with the U.S. Department of War to accelerate PAC-3 Missile Segment Enhancement interceptor output, lifting annual capacity to about 2,000 from roughly 600 over a seven-year agreement. “We will create unprecedented capacity for PAC-3 MSE production,” Chairman and CEO Jim Taiclet said. Media – Lockheed Martin

Even after Thursday’s premarket pop, the stock is coming off a sharp dip and remains well inside a wide recent range. Lockheed’s 52-week high is $538.73, according to MarketWatch. Buybacks, the policy target in the latest order, are when a company repurchases its own shares, which can boost earnings per share and often supports dividend-heavy stocks.

But there’s a catch for bulls: the executive order’s enforcement mechanics — and which contractors would be tagged as “underperforming” — remain the big unknown, and any budget push still runs through Congress. If rates jump on Friday’s jobs data, the sector’s rally could fade quickly.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
Tesco shares slide as Christmas update disappoints despite profit outlook lift
Previous Story

Tesco shares slide as Christmas update disappoints despite profit outlook lift

Nvidia’s China H200 payment demand hits chip stocks premarket as Intel pops, TSMC sinks
Next Story

Nvidia’s China H200 payment demand hits chip stocks premarket as Intel pops, TSMC sinks

Go toTop